Literature DB >> 14726809

A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia.

Salil Goorha1, Martha J Glenn, Elizabeth Drozd-Borysiuk, Zhong Chen.   

Abstract

PURPOSE: To investigate a simplified panel of fluorescent in-situ hybridization (FISH) probes for evaluation of patients with chronic lymphocytic leukemia (CLL) and to correlate results from this technique with known prognostic factors.
METHODS: We retrospectively reviewed the FISH and conventional cytogenetic results, and clinical and laboratory data of 44 patients with CLL.
RESULTS: FISH was more sensitive than conventional cytogenetics in detecting genomic aberrations (75% vs. 16%, P < 0.0001). Trisomy 12 was significantly correlated with the cell surface marker of CD38 expression (P = 0.0017).
CONCLUSION: This FISH panel reliably detects prognostically important genomic abnormalities in CLL and is suitable for widespread use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726809     DOI: 10.1097/01.gim.0000105741.57923.08

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  5 in total

1.  Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium.

Authors:  Stephanie A Smoley; Daniel L Van Dyke; Neil E Kay; Nyla A Heerema; Marie L Dell' Aquila; Paola Dal Cin; Prasad Koduru; Ayala Aviram; Laura Rassenti; John C Byrd; Kanti R Rai; Jennifer R Brown; Andrew W Greaves; Jeanette Eckel-Passow; Donna Neuberg; Thomas J Kipps; Gordon W Dewald
Journal:  Cancer Genet Cytogenet       Date:  2010-12

2.  Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience.

Authors:  Eiman A Al Zaabi; Louis A Fernandez; Irene A Sadek; D Christie Riddell; Wenda L Greer
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

3.  Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia.

Authors:  Wei Xu; Jian-Yong Li; Jin-Lan Pan; Hai-Rong Qiu; Yun-Feng Shen; Li Li; Ya-Fang Wu; Yong-Quan Xue
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

4.  Chronic lymphocytic leukemia with t(14;18)(q32;q21).

Authors:  Guilin Tang; Haley E Banks; Rachel L Sargent; L Jeffrey Medeiros; Lynne V Abruzzo
Journal:  Hum Pathol       Date:  2012-10-16       Impact factor: 3.466

5.  BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients.

Authors:  Eyad Alhourani; Moneeb A K Othman; Joana B Melo; Isabel M Carreira; Beata Grygalewicz; Dragana Vujić; Zeljko Zecević; Gordana Joksić; Anita Glaser; Beate Pohle; Cordula Schlie; Sven Hauke; Thomas Liehr
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.